Weekly Spotlight - 09.01.25

Community

Share Your Story, Inspire Hope

Your journey can be a beacon of hope and a source of strength for others in our community. Together, we can build a stronger, more supportive community. Your story matters, and it deserves to be heard. Fill in this form to be featured.

Latest News

Rare Case of Autoimmune Hepatitis and Liver Disease Overlap in Male Patient

A rare case of a male patient with both autoimmune hepatitis and primary biliary cholangitis is discussed. The patient's symptoms and treatment outcomes are detailed, highlighting the challenges in managing this overlap syndrome and the importance of tailored therapeutic approaches for such complex conditions.

COUR Pharmaceuticals Gains FDA Orphan Drug Status for New Treatment in Rare Liver Disease

COUR Pharmaceuticals has received FDA Orphan Drug Designation for CNP-104, a potential treatment for primary biliary cholangitis. This designation could accelerate the development and approval process for this drug, offering new hope for patients with this condition. The designation also provides certain incentives and benefits to the company.

FDA Grants Orphan Drug Designation for New Treatment in Rare Liver Disease

The FDA has granted orphan drug designation to CNP-104, a potential treatment for primary biliary cholangitis. This designation aims to expedite the development and review process for this drug, which could offer new hope for patients suffering from this condition.